Minicircle DNA is Superior to Plasmid DNA in Eliciting Antigen-specific CD8 super(+) T-cell Responses

Clinical trials reveal that plasmid DNA (pDNA)-based gene delivery must be improved to realize its potential to treat human disease. Current pDNA platforms suffer from brief transgene expression, primarily due to the spread of transcriptionally repressive chromatin initially deposited on plasmid bac...

Full description

Saved in:

Bibliographic Details
Published in:	Molecular therapy Vol. 21; no. 8; pp. 1526 - 1535
Main Authors:	Dietz, Wynette M, Skinner, Nicole E B, Hamilton, Sara E, Jund, Michelle D, Heitfeld, Bruce M, Litterman, Adam J, Hwu, Patrick, Chen, Zhi-Ying, Salazar, Andres M, Ohlfest, John R, Blazar, Bruce R, Pennell, Christopher A, Osborn, Mark J
Format:	Journal Article
Language:	English
Published:	01-08-2013
Subjects:	Listeria monocytogenes
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Clinical trials reveal that plasmid DNA (pDNA)-based gene delivery must be improved to realize its potential to treat human disease. Current pDNA platforms suffer from brief transgene expression, primarily due to the spread of transcriptionally repressive chromatin initially deposited on plasmid bacterial backbone sequences. Minicircle (MC) DNA lacks plasmid backbone sequences and correspondingly confers higher levels of sustained transgene expression upon delivery, accounting for its success in preclinical gene therapy models. In this study, we show for the first time that MC DNA also functions as a vaccine platform. We used a luciferase reporter transgene to demonstrate that intradermal delivery of MC DNA, relative to pDNA, resulted in significantly higher and persistent levels of luciferase expression in mouse skin. Next, we immunized mice intradermally with DNA encoding a peptide that, when presented by the appropriate major histocompatibility complex class I molecule, was recognized by endogenous CD8 super(+) T cells. Finally, immunization with peptide-encoding MC DNA, but not the corresponding full-length (FL) pDNA, conferred significant protection in mice challenged with Listeria monocytogenes expressing the model peptide. Together, our results suggest intradermal delivery of MC DNA may prove more efficacious for prophylaxis than traditional pDNA vaccines.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Feature-2
ISSN:	1525-0016 1525-0024
DOI:	10.1038/mt.2013.85